Bank of Montreal’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-33,243
| Closed | -$54.9K | – | 3869 |
|
2022
Q4 | $54.9K | Sell |
33,243
-1,570
| -5% | -$2.59K | ﹤0.01% | 3080 |
|
2022
Q3 | $73 | Sell |
34,813
-200,794
| -85% | -$421 | ﹤0.01% | 3074 |
|
2022
Q2 | $492 | Buy |
235,607
+178,716
| +314% | +$373 | ﹤0.01% | 2327 |
|
2022
Q1 | $144K | Buy |
56,891
+45,045
| +380% | +$114K | ﹤0.01% | 3089 |
|
2021
Q4 | $57K | Sell |
11,846
-1,578
| -12% | -$7.59K | ﹤0.01% | 3143 |
|
2021
Q3 | $105K | Buy |
13,424
+3,252
| +32% | +$25.4K | ﹤0.01% | 3238 |
|
2021
Q2 | $101K | Sell |
10,172
-62,959
| -86% | -$625K | ﹤0.01% | 3192 |
|
2021
Q1 | $566K | Sell |
73,131
-80,821
| -52% | -$626K | ﹤0.01% | 2232 |
|
2020
Q4 | $1.11M | Buy |
153,952
+128,294
| +500% | +$922K | ﹤0.01% | 1829 |
|
2020
Q3 | $272K | Sell |
25,658
-4,646
| -15% | -$49.3K | ﹤0.01% | 2235 |
|
2020
Q2 | $235K | Buy |
30,304
+28,734
| +1,830% | +$223K | ﹤0.01% | 2309 |
|
2020
Q1 | $3K | Sell |
1,570
-15,802
| -91% | -$30.2K | ﹤0.01% | 3504 |
|
2019
Q4 | $58K | Sell |
17,372
-158,613
| -90% | -$530K | ﹤0.01% | 3261 |
|
2019
Q3 | $376K | Sell |
175,985
-124,556
| -41% | -$266K | ﹤0.01% | 2157 |
|
2019
Q2 | $802K | Buy |
300,541
+9,780
| +3% | +$26.1K | ﹤0.01% | 1835 |
|
2019
Q1 | $1.38M | Buy |
290,761
+281,884
| +3,175% | +$1.34M | ﹤0.01% | 1631 |
|
2018
Q4 | $21K | Sell |
8,877
-147,909
| -94% | -$350K | ﹤0.01% | 3279 |
|
2018
Q3 | $690K | Buy |
156,786
+47,916
| +44% | +$211K | ﹤0.01% | 1958 |
|
2018
Q2 | $784K | Buy |
+108,870
| New | +$784K | ﹤0.01% | 1920 |
|
2017
Q2 | – | Sell |
-488
| Closed | -$2K | – | 3922 |
|
2017
Q1 | $2K | Hold |
488
| – | – | ﹤0.01% | 3562 |
|
2016
Q4 | $3K | Hold |
488
| – | – | ﹤0.01% | 3534 |
|
2016
Q3 | $4K | Hold |
488
| – | – | ﹤0.01% | 3500 |
|
2016
Q2 | $3K | Buy |
+488
| New | +$3K | ﹤0.01% | 3562 |
|